Log In
Print this Print this

IV Taigexyn, nemonoxacin

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionNon-fluorinated quinolone antibiotic topoisomerase inhibitor
Molecular Target Topoisomerase IV
Mechanism of ActionTopoisomerase IV inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPneumonia
Indication DetailsTreat community-acquired pneumonia (CAP)
Regulatory Designation
PartnerR-Pharm CJSC;
TaiGen Biopharmaceuticals Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today